These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10778173)

  • 1. [CA72-4 (TAG72)].
    Konishi F; Konishi K
    Nihon Rinsho; 1999 Dec; 57 Suppl():498-501. PubMed ID: 10778173
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of CA72-4 as a tumor marker in patients with gastric cancer].
    Ubukata H; Katano M; Motohashi G; Kasuga T; Takemura A; Tabuchi T; Tabuchi T
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1821-4. PubMed ID: 14619529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical efficacy of CA 72-4 as serum marker for gastric cancer in comparison with CA19-9 and CEA.
    Kodama I; Koufuji K; Kawabata S; Tetsu S; Tsuji Y; Takeda J; Kakegawa T
    Int Surg; 1995; 80(1):45-8. PubMed ID: 7657491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of CA72-4 as a follow up of recurrent gastric cancer--comparison with CEA and CA19-9].
    Takahashi Y; Mai M
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):515-8. PubMed ID: 1558402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CA72 -4 (TAG72)].
    Mizumoto Y; Kyo S; Takakura M; Nakamura M; Inoue M
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():717-9. PubMed ID: 20963906
    [No Abstract]   [Full Text] [Related]  

  • 6. [The significance of pepsinogen with its subgroup and CA72-4 associate detect applied to early diagnostic and prognosis judgment on gastric cancer].
    Lin HZ; Chen L; Li XC; Zhou DF; Cui JY
    Zhonghua Wai Ke Za Zhi; 2004 Dec; 42(24):1505-8. PubMed ID: 15733483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
    Lai IR; Lee WJ; Huang MT; Lin HH
    Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Histological localization of TAG72 in gastric cancers and a clinico-pathological study of the CA72-4 serum values].
    Konishi F; Matzunou H; Konishi K; Yamamichi N
    Gan No Rinsho; 1990 May; 36(6):691-9. PubMed ID: 2161468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differential diagnosis of chronic ulcer and ulcerated cancer of the stomach].
    Roman LD; Stoĭko IuM; Verbitskiĭ VG; Karachun AM
    Vopr Onkol; 2000; 46(2):217-20. PubMed ID: 10853426
    [No Abstract]   [Full Text] [Related]  

  • 10. Pre-operative serum levels of CA72-4 in patients with gastric adenocarcinoma.
    Ikeguchi M; Katano K; Saitou H; Tsujitani S; Maeta M; Kaibara N
    Hepatogastroenterology; 1997; 44(15):866-71. PubMed ID: 9222706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of serum tumor markers in the diagnosis of gastric cancer.
    Fan B; Xiong B
    Hepatogastroenterology; 2011; 58(105):239-45. PubMed ID: 21510322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An abnormal elevation of serum CA72-4 by ganoderma lucidum spore powder.
    Liang Y; He M; Fan X; Ye W; Yang Z; Zhong R
    Ann Clin Lab Sci; 2013; 43(3):337-40. PubMed ID: 23884232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening the gastric cancer related tumor markers from multi-tumor markers protein chip with kappa coefficient and cost-effectiveness analysis.
    Hou JX; Yang XQ; Chen C; Jiang Q; Yang GL; Li Y
    Hepatogastroenterology; 2011; 58(106):632-6. PubMed ID: 21661444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A clinical evaluation of the CA 72-4 serum level as a possible tumor marker].
    Jibiki K; Takeda M; Abe H; Ito M; Odagiri E; Demura R; Demura H; Takizawa K
    Gan No Rinsho; 1990 Oct; 36(12):2146-52. PubMed ID: 2232183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The clinico-diagnostic significance of tumor markers in malignant neoplasms].
    Seliuzhitskiĭ IV; Skvortsov SV; Lytsar' BN
    Voen Med Zh; 1993 Mar; (3):27-8. PubMed ID: 8498043
    [No Abstract]   [Full Text] [Related]  

  • 16. [KMO1].
    Kamigaki T; Kuroda Y
    Nihon Rinsho; 1999 Dec; 57 Suppl():517-9. PubMed ID: 10778178
    [No Abstract]   [Full Text] [Related]  

  • 17. [The clinical information value of an immunoenzyme study of the tumor markers CA-19-9, CEA and AFP in cancer of the stomach, pancreas, colon and rectum].
    Ial'chenko NA; Lagutin VD; Lavik NN; Musin II
    Vopr Onkol; 1991; 37(9-10):921-4. PubMed ID: 1726842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CA50].
    Kawabe T
    Nihon Rinsho; 1999 Dec; 57 Suppl():462-5. PubMed ID: 10778165
    [No Abstract]   [Full Text] [Related]  

  • 19. [KMO1].
    Kamigaki T
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():736-8. PubMed ID: 20960860
    [No Abstract]   [Full Text] [Related]  

  • 20. [CA72-4 (TAG-72)].
    Maida Y; Kyo S; Inoue M
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():672-4. PubMed ID: 16149608
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.